Ellsworth Growth and Income Fund Ltd. Increases Annual Distribution 20% to $0.76 From $0.64
Globenewswire· 2025-08-26 11:30
Group 1 - The Board of Trustees of Ellsworth Growth and Income Fund Ltd. has increased the quarterly distribution to $0.19 per share, a 20% increase from the previous $0.16 per share [1] - The new distribution will commence in December 2025, raising the annualized distribution rate from $0.64 to $0.76 per share [1] - The increase in distribution reflects the Fund's strong NAV total return of 18% year to date [1] Group 2 - Ellsworth Growth and Income Fund Ltd. is a diversified, closed-end management investment company with total net assets of $199 million [2] - The Fund primarily invests in convertible securities and common stock, aiming to provide income and potential capital appreciation [2] - Gabelli Funds, LLC, a subsidiary of GAMCO Investors, Inc., manages the Fund [2]
GAMCO Natural Resources, Gold & Income Trust Increases Monthly Distribution 25%
Globenewswire· 2025-08-26 11:30
RYE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of GAMCO Natural Resources, Gold & Income Trust (NYSE: GNT) (the “Fund”) authorized a 25% increase in the monthly cash distribution to $0.05 per share from $0.04 per share, beginning in October 2025. The increase reflects the strength of the Fund’s NAV total return of 28% year to date. Investors should carefully consider the investment objectives, risks, charges, and expenses of the Fund before investing. For more information regarding the F ...
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
Globenewswire· 2025-08-26 11:30
Group 1 - Curanex Pharmaceuticals Inc. has priced its initial public offering (IPO) of 3,750,000 shares at $4.00 per share, aiming for gross proceeds of $15 million [1] - The IPO is expected to close on August 27, 2025, and shares will begin trading on the Nasdaq Capital Market under the ticker symbol "CURX" [1] - Underwriters have an option to purchase an additional 562,500 shares within 45 days of the offering's close [1] Group 2 - Proceeds from the offering will be used for the development of the lead product candidate, Phyto-N, for ulcerative colitis, including FDA-required studies and IND application preparation [2] - Curanex Pharmaceuticals is focused on developing botanical drugs for inflammatory diseases, with Phyto-N being a botanical extract with proven anti-inflammatory properties [7][8] - Phyto-N has been validated in animal models for six inflammatory diseases, with the primary indication being moderate to severe ulcerative colitis [8] Group 3 - Dominari Securities LLC is the lead underwriter for the offering, with Pacific Century Securities LLC and Revere Securities LLC as co-underwriters [3] - A registration statement for the offering was filed with the SEC and declared effective on August 12, 2025 [4] - The final prospectus related to the offering will be available on the SEC's website [4][5]
Bowman to Attend D.A. Davidson Industrials Conference in September
Globenewswire· 2025-08-26 11:30
RESTON, Va., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, announced it will participate in D.A. Davidson’s 24th Annual Diversified Industrials & Services Conference held September 17-19. The conference will be at The Four Seasons Hotel in Nashville, Tennessee. About Bowman Consulting Group Ltd.Headquartered in Reston, Virginia, Bowman is a national engineering services firm delivering infrastructure, technology an ...
DraftKings Launches Responsible Gaming Education Month Campaign Featuring Super Bowl Tickets Sweepstakes
Globenewswire· 2025-08-26 11:30
Core Insights - DraftKings Inc. is launching a monthlong campaign for Responsible Gaming Education Month (RGEM) to promote responsible gaming through a sweepstakes offering NFL tickets and a trip to Super Bowl LX [1][2] - The campaign encourages customer engagement with responsible gaming tools like My Budget Builder and My Stat Sheet, aiming to foster a more informed gaming culture [2][4] Group 1: Campaign Details - The sweepstakes will run from August 26 to September 8, allowing customers to win NFL regular season tickets by using My Budget Builder [2] - Each week will introduce new responsible gaming engagement methods, with additional ticket giveaways and a grand prize trip to Super Bowl LX for using My Stat Sheet [2][3] Group 2: Tool Highlights - My Budget Builder, launched in June 2025, builds on the success of My Stat Sheet, which has been utilized by approximately 3.4 million customers to track their gaming activity [3] - DraftKings emphasizes the integration of responsible gaming tools throughout the customer journey, reinforcing its commitment to responsible play [4] Group 3: Company Commitment - DraftKings is dedicated to providing a fun and responsible gaming experience, sharing a new Code of Responsible Play with customers to promote responsible behavior [4] - The company aims to maintain responsible gaming as a core aspect of its product design and long-term strategy as it continues to grow [4][6]
Altimmune to Participate in Upcoming Investor Conferences
Globenewswire· 2025-08-26 11:30
Company Overview - Altimmune, Inc. is a late clinical-stage biopharmaceutical company focused on developing peptide-based therapeutics for liver and cardiometabolic diseases [1] - The company's lead product candidate is pemvidutide, a GLP-1/glucagon dual receptor agonist targeting MASH, Alcohol Use Disorder (AUD), Alcohol-Associated Liver Disease (ALD), and obesity [1] Investor Engagement - Management will participate in several upcoming investor conferences, including the Wells Fargo Healthcare Conference on September 5, 2025, and the H.C. Wainwright Global Investment Conference on September 9, 2025 [3] - The Morgan Stanley Global Healthcare Conference is scheduled for September 10, 2025, where a fireside chat will take place [3] - These events will include one-on-one meetings and webcasts accessible via the Altimmune website [3]
FuelCell Energy Announces Third Quarter 2025 Results Conference Call on September 9, 2025 at 10:00 A.M. Eastern Time
Globenewswire· 2025-08-26 11:30
Company Announcement - FuelCell Energy, Inc. will release its third quarter 2025 results on September 9, 2025, before the stock market opens [1] - Following the results announcement, the company will host a conference call with investors at 10:00 a.m. Eastern Time on the same day [1] Conference Call Details - The conference call will be accessible via webcast on the company's website or by telephone [1] - A replay of the conference call will be available approximately two hours after the conclusion of the call on the company's Investors' page [2] Company Overview - FuelCell Energy provides clean and reliable energy solutions that enable customers to access power quickly and manage emissions [3] - The company's systems are efficient, scalable, and fuel-flexible, operating on natural gas, biofuels, or hydrogen, and provide steady baseload electricity [3] - With over 55 years of expertise and nearly 200 modules deployed, FuelCell Energy assists customers in achieving their energy goals [3]
Bancroft Fund Ltd. Increases Annual Distribution 10% to $1.40 From $1.28
Globenewswire· 2025-08-26 11:30
RYE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- The Board of Trustees of Bancroft Fund Ltd. (NYSE American: BCV) (the “Fund”) increased the quarterly distribution to $0.35 per share. The increased quarterly distributions will commence with the distribution payable in December 2025. This is a 10% increase from $0.32 per share, bringing the annualized distribution rate to $1.40 from $1.28 per share. The increase underscores the strength of the Fund’s NAV total return of 20% year to date. Investors should careful ...
BriaCell’s Bria-OTS+™ Mechanism of Action Validated in Highly Rated Peer Reviewed Cancer Journal
Globenewswire· 2025-08-26 11:30
Data from BriaCell and the US National Cancer Institute (NCI) support the cancer cell killing potential of BriaCell’s Bria-OTS+ platformBria-OTS+, a novel personalized, off-the-shelf, semi-allogeneic cellular immunotherapy may address urgent unmet medical needs for patients with cancer This study was conducted in collaboration with the NCI PHILADELPHIA and VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “C ...
Draganfly Uniquely Positioned to Support Canada's New $2 Billion Military Commitment to Ukraine with Advanced Drone and Tactical Capabilities
Globenewswire· 2025-08-26 11:15
Core Insights - Draganfly Inc. is strategically positioned to support Canada's $2 billion military aid package to Ukraine, with over $220 million allocated for drone and electronic warfare capabilities [1][2] - The company's extensive experience in drone technology and its active involvement in Ukraine since 2022 enhance its ability to contribute to defense initiatives [2][3] - Draganfly's capabilities include advanced UAV solutions, counter-drone systems, and support for ISR, demining, and logistics [3][4] Strategic Alignment - Canada's military aid underscores its commitment to defending democracy and resisting authoritarianism, with a significant portion of funding directed towards advanced drone technologies [2] - The partnership between Canadian and Ukrainian defense companies is emphasized, with Draganfly's engineering expertise being a key asset [2][3] Military-Grade Capabilities - Draganfly has a proven track record in defense and humanitarian response, showcasing its advanced drone systems and counter-drone technologies [3] - The company is expanding its capabilities through domestic and international defense contracts, R&D investments, and partnerships with NATO-aligned nations [3] Company Overview - Draganfly Inc. is a pioneer in drone solutions, AI-driven software, and robotics, with over 25 years of innovation in the industry [4] - The company focuses on delivering reliable technology for various applications, including public safety, agriculture, and industrial inspections [4]